Parabilis Medicines vs Target Pharmacy

Side-by-side comparison of AI visibility scores, market position, and capabilities

Target Pharmacy leads in AI visibility (79 vs 52)
Parabilis Medicines logo

Parabilis Medicines

ChallengerHealthcare & Life Sciences

AI Peptide Therapeutics

Clinical-stage biotech; raised $305M Series F (Jan 2026) for AI-optimized peptides targeting intracellular cancer proteins previously considered undruggable; oncology-first pipeline

AI VisibilityBeta
Overall Score
C52
Category Rank
#302 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
49
Perplexity
54
Gemini
58

About

Parabilis Medicines is a clinical-stage biotechnology company applying AI to the design of peptide-based therapeutics targeting proteins previously considered undruggable, with a primary focus on oncology. The company was founded on the insight that AI-optimized peptides — short chains of amino acids — can be engineered to reach and modulate intracellular protein targets that small molecules and biologics cannot access. Parabilis uses proprietary computational platforms to design, screen, and optimize peptide candidates with improved cell permeability, stability, and target selectivity.\n\nThe company's pipeline is centered on cancer proteins that drive tumor growth but lack conventional binding pockets for small molecule inhibition. Parabilis's AI-designed peptides are engineered to penetrate cancer cells and disrupt these oncogenic interactions, potentially unlocking entirely new therapeutic options for patients with tumors driven by these targets. The approach also has potential applications in other diseases where intracellular protein-protein interactions are central to pathology.\n\nParabilis raised $305M in a Series F round in January 2026, one of the largest biotech fundraises of that period. The financing was designed to advance its lead programs through clinical development and expand its pipeline of AI-designed peptide candidates. With over $300M in fresh capital, Parabilis is one of the most heavily funded companies in the emerging AI peptide therapeutics space, positioning it to compete with both traditional peptide drug developers and newer AI-native biotech platforms.

Full profile
Target Pharmacy logo

Target Pharmacy

LeaderHealthcare

Pharmacy Retail

CVS Health-operated pharmacy inside Target (NYSE: TGT) stores serving 100M weekly shoppers; $1.9B 2015 Target-to-CVS pharmacy acquisition creating store-within-store pharmacy integrated with Target Circle loyalty.

AI VisibilityBeta
Overall Score
B79
Category Rank
#21 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
75
Gemini
74

About

Target Pharmacy refers to the pharmacy services within Target Corporation's (NYSE: TGT) retail stores — providing prescription dispensing, immunizations, and health consultations to Target shoppers combining pharmacy errands with retail shopping. In 2015, Target sold its pharmacy and clinic operations to CVS Health (NYSE: CVS) for $1.9 billion, converting the in-store locations to CVS Pharmacy branding under a long-term licensing agreement — making what shoppers call "Target Pharmacy" operationally a CVS pharmacy located inside Target's 1,900+ US stores, operating under CVS management while Target shoppers earn Target Circle rewards on eligible pharmacy purchases.

Full profile

AI Visibility Head-to-Head

52
Overall Score
79
#302
Category Rank
#21
79
AI Consensus
83
stable
Trend
stable
49
ChatGPT
79
54
Perplexity
75
58
Gemini
74
51
Claude
79
52
Grok
80

Key Details

Category
AI Peptide Therapeutics
Pharmacy Retail
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Parabilis Medicines
AI Peptide Therapeutics
Only Target Pharmacy
Pharmacy Retail

Integrations

Only Parabilis Medicines
Target Pharmacy is classified as company (part of CVS Health).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.